Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling.
Ding L, Chen X, Zhang W, Dai X, Guo H, Pan X, Xu Y, Feng J, Yuan M, Gao X, Wang J, Xu X, Li S, Wu H, Cao J, He Q, Yang B.
Ding L, et al. Among authors: pan x.
J Clin Invest. 2023 Jan 3;133(1):e154754. doi: 10.1172/JCI154754.
J Clin Invest. 2023.
PMID: 36594471
Free PMC article.